LBH and cutaneous melanoma: Significant LBH underexpression was further detected in skin cutaneous melanoma (SKCM, −1.4 to −2.1-fold), ovarian serous cystadenocarcinoma (OV, −1.5 to −1.9-fold), and, in the larger TCGA dataset, also in cervical squamous cell carcinoma (CESC, −1.8-fold), and in uterine-endometrial (UCEC/Uterine Corpus Endometrial Carcinoma; −2.3-fold) cancers (Fig. 1E.ii–iv; Fig. S1A.xv–xvi, and Fig. S1B.v).